>
Sema4 Holdings logo

SMFR - Sema4 Holdings Share Price

$7.58 0.2  3.1%

Last Trade - 9:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.35bn
Enterprise Value £1.35bn
Revenue £n/a
Position in Universe 2391st / 7245
Bullish
Bearish
Unlock SMFR Revenue
Momentum
Relative Strength (%)
1m -23.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -73.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 201 259.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, Sema4Holdings Corp revenues was not reported. Net loss totaledto $45.5M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SMFR Revenue Unlock SMFR Revenue

Net Income

SMFR Net Income Unlock SMFR Revenue

Normalised EPS

SMFR Normalised EPS Unlock SMFR Revenue

PE Ratio Range

SMFR PE Ratio Range Unlock SMFR Revenue

Dividend Yield Range

SMFR Dividend Yield Range Unlock SMFR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SMFR EPS Forecasts Unlock SMFR Revenue
Profile Summary

Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user’s baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user’s baby health by screening childhood diseases.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
No. of Shareholders: 2
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 251,259,152
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SMFR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SMFR
Upcoming Events for SMFR
Frequently Asked Questions for Sema4 Holdings
What is the Sema4 Holdings share price?

As of 9:00pm, shares in Sema4 Holdings are trading at $7.58, giving the company a market capitalisation of £1.35bn. This share price information is delayed by 15 minutes.

How has the Sema4 Holdings share price performed this year?

Shares in Sema4 Holdings are currently trading at $7.58 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sema4 Holdings price has moved by % over the past year.

What are the analyst and broker recommendations for Sema4 Holdings?

There are no analysts currently covering Sema4 Holdings.

When will Sema4 Holdings next release its financial results?

Sema4 Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Sema4 Holdings dividend yield?

Sema4 Holdings does not currently pay a dividend.

Does Sema4 Holdings pay a dividend?

Sema4 Holdings does not currently pay a dividend.

When does Sema4 Holdings next pay dividends?

Sema4 Holdings does not currently pay a dividend.

How do I buy Sema4 Holdings shares?

To buy shares in Sema4 Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sema4 Holdings?

Shares in Sema4 Holdings are currently trading at $7.58, giving the company a market capitalisation of £1.35bn.

Where are Sema4 Holdings shares listed? Where are Sema4 Holdings shares listed?

Here are the trading details for Sema4 Holdings:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: SMFR
What kind of share is Sema4 Holdings?

Based on an overall assessment of its quality, value and momentum, Sema4 Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sema4 Holdings share price forecast 2021?

Shares in Sema4 Holdings are currently priced at $7.58. At that level they are trading at 72.38% discount to the analyst consensus target price of 0.00.

Analysts covering Sema4 Holdings currently have a consensus Earnings Per Share (EPS) forecast of -1.099 for the next financial year.

How can I tell whether the Sema4 Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sema4 Holdings. Over the past six months, the relative strength of its shares against the market has been -52.17%. At the current price of $7.58, shares in Sema4 Holdings are trading at -42.12% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sema4 Holdings PE Ratio?

We were not able to find PE ratio data for Sema4 Holdings.

Who are the key directors of Sema4 Holdings?

We were unable to find the directors for Sema4 Holdings.

Who are the major shareholders of Sema4 Holdings?

Here are the top five shareholders of Sema4 Holdings based on the size of their shareholding:

Icahn School of Medicine at Mount Sinai Corporation
Percentage owned: 36.79% (88.4m shares)
The Blackstone Group Investment Advisor/Hedge Fund
Percentage owned: 10.43% (25.1m shares)
Deerfield Management Company, L.P. Hedge Fund
Percentage owned: 5.77% (13.8m shares)
Casdin (Eli) Individual Investor
Percentage owned: 4.58% (11.0m shares)
CMLS Holdings LLC Corporation
Percentage owned: 4.58% (11.0m shares)
Similar to SMFR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.